Home

LOU SILVERMAN

CIK 1249935 · Chief Executive Officer · last filed 2026-07-06

LOU SILVERMAN is a Chief Executive Officer who has filed 41 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing shows the insider had shares withheld for taxes covering $43.8K of OCX on Jul 6, 2026. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $312.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$312.2K

Companies

4

Total Filings

41

Lifetime Open-Market Net

-$6.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Insight Molecular Diagnostics Inc. (OCX) Delisted Director 55,807 $3.20 $178.6K $0 5 2026-07-06
STAA Director 12,658 $24.64 $311.9K -$6.86M 16 2026-06-22
BTX Director 38 $8.98 $341 $0 4 2016-10-31
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Director 14,183 — — $0 8 2013-05-29

Recent Filings

41 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 Insight Molecular Diagnostics Inc. (OCX) Delisted Tax (F) −7,700 -$43.8K EDGAR
2026-06-22 STAA Mixed +10,683 $0 EDGAR
2026-06-15 Insight Molecular Diagnostics Inc. (OCX) Delisted Grant (A) +26,943 $0 EDGAR
2026-06-03 — Grant (A) +42,507 $0
2025-07-03 Insight Molecular Diagnostics Inc. (OCX) Delisted Grant (A) +35,000 $0 EDGAR
2025-06-20 STAA Grant (A) — $0 EDGAR
2025-06-03 — Grant (A) +46,512 $200.0K
2025-05-13 STAA Grant (A) — $0 EDGAR
2025-03-26 — Grant (A) +10,112 $0
2024-07-03 Insight Molecular Diagnostics Inc. (OCX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 41
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.